Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 4Phase 3 3Phase 2/3 1Phase 1/2 1

Status

Completed 4

Sponsor Class

INDUSTRY 4OTHER 2

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 3Sarcoma 1

Conditions

Solid Tumor 1Sarcoma 1Locally Advanced Solid Tumors 1Advanced Solid Tumor 1

Interventions

pembrolizumab 301Paclitaxel 206Carboplatin 199Gemcitabine 173Cisplatin 138Docetaxel 137Cyclophosphamide 135Nivolumab 129Bevacizumab 118Injections 111fludarabine 95atezolizumab 91Pemetrexed 90Dexamethasone 90Cetuximab 90Fluorouracil 84Irinotecan 77Rituximab 72Capecitabine 72venetoclax 70Azacitidine 70130-nm albumin-bound paclitaxel 67Leucovorin 65Fulvestrant 58Oxaliplatin 57durvalumab 56Trastuzumab 56Lenalidomide 55Ipilimumab 55Midazolam 54

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × INDUSTRY × entrectinib × Clear all
NCT03056599 2021-09-24

Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma

Presage Biosciences

Phase 1 Completed
23 enrolled
Sarcoma

Sarcoma

NCT02097810 2021-06-09

STARTRK-1

Hoffmann-La Roche

Phase 1 Completed
84 enrolled 1 FDA
Other solid neoplasm

Locally Advanced Solid Tumors

NCT03961100 2020-09-07

A Performance and Bioavailability Study of Entrectinib in Healthy Volunteers.

Genentech, Inc.

Phase 1 Completed
31 enrolled 14 charts
Other solid neoplasm

Solid Tumor

NCT03330990 2018-08-21

Evaluate the Effect of Entrectinib on the Pharmacokinetics of Midazolam in Cancer Patients

Hoffmann-La Roche

Phase 1 Completed
15 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡